Ignyta Acquires Exclusive Rights to Taladegib Oncology Program from Lilly for $2M, ~1.2M Ignyta Shares
November 08, 2015 at 16:48 PM EST
Ignyta, Inc. (Nasdaq: RXDX) today announced the exclusive license of worldwide rights relating to Eli Lilly and Company's ...